




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
ChemotherapeuticMedicineLiChenDepartmentofPharmacologySchoolofBasicMedicalScienceJilinUniversityAntimicrobialagentsAntiparasiticagents(44)Anticancerdrug(45)Antibacterialdrugs(35-40)Antifungaldrugs(41)AntiviraldrugsClassificationAntimicrobialAgents:GeneralConsiderationGeneralconceptMechanismofactionBacterialResistanceSection1GeneralConceptofAntimicrobialDrugsAntibacterialdrugs
Thedrugsthatinhibitorkillthebacterial,includingantibioticsandartificialdrugsAntibiotics
Theagentswhichareproducedbymicrobes,couldinhibitorkillothermicrobesgrowthandfinallydestroythem.Antibacterialspectrum
Theantibacterialrangeoftheanti-bacterialdrugsbroad-spectrumantibacterialdrugsnarrow-spectrumantibacterialdrugsBroad-spectrumantibacterialdrugsaffectawidevarietyofmicrobialspeciestetracycline,chloramphenicol,fluoroquinolonesNarrow-spectrumantibacterialdrugsactonlyonasingleoralimitedgroupsofmicroorganisms
isoniazid
Antibacterialactivity
Antibacterialdrug’scompetenceofinhibitingandkillingbacteriumBacteriostaticdrugs
Drugsthatinhibitthegrowthofthebacteriawithoutcausing
celldeathtetracyclines,macrolides,clindamycin,chloramphenicolandsulfonamidesBactericidaldrugs
Drugsthatkillbacteriaβ-lactams,Vancomycin,aminoglycosidesandfluoroquinolones.Minimalinhibitoryconcentration,MIC
ThelowestconcentrationofdrugthatinhibitsgrowthofthemicrobesMinimalbactericidalconcentration,MBCThelowestconcentrationofdrugthatkillmicrobesChemotherapeuticindex
Theratioofthetoxicdosetothetherapeuticdoseofchemotherapeuticmedicines
Post-antibioticeffect,PAE
AntibacterialactivitypersistsbeyondthetimethatmeasurabledrugispresentSection2MechanismofAntimicrobialActioncellwallsynthesisplasmamembraneintegrityProteinsynthesisnucleotide
synthesisfolatesynthesis.1.InhibitionsynthesisofbacterialcellwallFunction:1).MaintainBacterialshape2).Barrierfunction3).permeation
Cellwall:
peptidoglycanN-acetylatedmuramicacid(NAM)
N-acetylatedglucosamine(NAG)Vancomycin
-Lactamcytoplasmplasmamembranecellwall2.Increasedpermeabilityofcytoplasmicmembranes
Bacteriumlipid(phospholipid,glucolipid)proteinpolysaccharide(peptidoglycan)Fungi
ergosterol
1).Polymyxins:interactwithphospholipid2).Antifungalagents:
Polyenesbindtoergosterol
Azolesblockergosterolbiosynthesis3.InhibitionofproteinbiosynthesisRibosomeBigsubunitSmallsubunitBacterium70S50S23S,5SrRNA31proteins
30S16SrRNA21proteinsMammalian80S60S28S,5SrRNA49proteins
40S16SrRNA33proteinsPADecodingProteinBiosynthesisPAPAPATetracyclines(30S)Aminoglycosides(30S)Peptidyl
transferaseChloramphenicolLincomycin(50S)TranslocaseMacrolides(50S)Aminoglycosides(30S)1).DNAuncoiling:helicase2).primosomeandprimer:primase3).DNAreplication:
DNApolymerase DNAgyrase DNAligase4.Interferencewithnucleotidesynthesis
Rifampin:inhibitDNA-directedRNApolymeraseQuinolones:inhibitDNAgyrase,andDNAReplication5.InhibitionofthefolatemetabolismPABA+PteridineDihydropteroicacidDihydropteroate
synthaseDihydrofolateDihydrofolatereductase(DHFR)TetrahydrofolateprecursorPurine、pyrimidinenucleotideGlutamateSulfonamidesTrimethoprim
(TMP)MechanismofactionQuinolonesTetracyclinesAminoglycosides
Macrolides
ChloramphenicolLincomycinPolymyxinPolyenesAzoles
-lactamVancomycinDNAPlasmamembraneCellwallPABADHFATHFA50S50S50S30S30S30SmRNARifampinTMPSulfonamidesSection3BacterialResistance1.ClassificationofbacterialresistanceIntrinsicresistanceAcquiredresistanceGram-negativeorganismsVancomycinPseudomonasaeruginosa
Ampicillin
2.MechanismsofResistanceProductionofenzymesthatinactivatethedrugModificationoftargetsitesDecreasethepermeabilityofcellmembraneActivedrugeffluxfromthecellPenicillineresistance:
penicillinaseCephalosporinsresistance:
superbroadspectrumβ-Lactamase
(ESBLs)Lactamaseinhibitorresistance:
AmpCtypeenzymeβ-Lactamase
:1)ProductionofenzymesthatinactivatethedrugChloramphenicols:
acetyltransferase nucleosidetransferaseAminoglycosides:
phosphotransferase
acetyltransferaseMacrolides:
acetyltransferaseNonβ-Lactamase
:Modifytargetproteinbindingsite2)Modificationoftargetsites(2)ProducenewtargetproteinMacrolide
Methylationofanadenineofthe23SbacterialribosomalRNAMethicillinresistanceinstaphylococcipenicillinresistanceinpneumococciand
enterococci
NewPBPs
3)Decreasethepermeabilityofcelloutmembrane4)IncreasedactiveeffluxsystemOmpF
-lactam,Tetracyclines,Quinolones,ChloramphenicolEffluxtransporter:Accessoryprotein:outermembraneprotein:
DrugeffluxsystemIncreasedactiveeffluxsystem
-lactam,Tetracyclines,Quinolones,Chloramphenicol,Macrolides,MutationTransductionTransformationConjugation3.Transference
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 口腔黏膜疼痛的個(gè)案護(hù)理
- 陰式手術(shù)術(shù)中護(hù)理要點(diǎn)
- 2025至2030年鳳梨酥項(xiàng)目投資價(jià)值分析報(bào)告
- 2025至2030年中國廢酒精回收系統(tǒng)行業(yè)發(fā)展預(yù)測及投資策略報(bào)告
- 2025至2030年中國工商用制冷、空調(diào)設(shè)備零部件行業(yè)發(fā)展預(yù)測及投資策略報(bào)告
- 護(hù)理安全文化節(jié)針刺傷防護(hù)與處理
- 2025年靜電粉末涂裝設(shè)備項(xiàng)目可行性研究報(bào)告
- 2025年環(huán)境實(shí)驗(yàn)機(jī)項(xiàng)目可行性研究報(bào)告
- 電力現(xiàn)場安全培訓(xùn)
- 物聯(lián)網(wǎng)規(guī)劃設(shè)計(jì)與構(gòu)建
- 全國統(tǒng)一卷試題及答案
- 礦石采購合同范本
- 2024年甘肅省煙草專賣局招聘考試真題
- 2025年龍江森工集團(tuán)權(quán)屬林業(yè)局有限公司招聘筆試參考題庫含答案解析
- (二模)溫州市2025屆高三第二次適應(yīng)性考試英語試卷(含答案)+聽力音頻+聽力原文
- DeepSeek+AI組合精準(zhǔn)賦能教師教學(xué)能力進(jìn)階實(shí)戰(zhàn) 課件 (圖片版)
- 《哈哈鏡笑哈哈》名師課件2022
- 2025年纖維檢驗(yàn)員(高級(jí))職業(yè)技能鑒定參考試題庫(含答案)
- 傳統(tǒng)皮影戲在小學(xué)藝術(shù)教育的應(yīng)用與創(chuàng)新實(shí)踐
- 2025年國家會(huì)展中心上海有限責(zé)任公司招聘筆試參考題庫含答案解析
- 《大數(shù)據(jù)時(shí)代對會(huì)計(jì)行業(yè)產(chǎn)生的影響探究》10000字【論文】
評(píng)論
0/150
提交評(píng)論